Healthcare - Biotechnology - NASDAQ - US
$ 6.175
-10.6 %
$ 1.73 B
Market Cap
-4.23
P/E
BALANCE SHEET
654 M
ASSETS
190 M
LIABILITIES
463 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Recursion Pharmaceuticals, Inc.
| Current Assets | 438 M |
| Cash & Short-Term Investments | 392 M |
| Receivables | 3.09 M |
| Other Current Assets | 43.5 M |
| Non-Current Assets | 216 M |
| Long-Term Investments | 0 |
| PP&E | 120 M |
| Other Non-Current Assets | 95.4 M |
| Current Liabilities | 93.2 M |
| Accounts Payable | 3.95 M |
| Short-Term Debt | 12.3 M |
| Other Current Liabilities | 76.9 M |
| Non-Current Liabilities | 97.1 M |
| Long-Term Debt | 44.5 M |
| Other Non-Current Liabilities | 52.6 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 391.6 | 549.9 | 285.1 | 262.1 | 69.9 |
| Short Term Investments | 0 | 0 | 231.4 | 0 | 0 |
| Receivables | 3.1 | 2.8 | 9.1 | 0.2 | 0.2 |
| Inventory | 0 | 1.3 | 1.6 | 5.0 | 5.3 |
| Other Current Assets | 43.5 | 17.1 | 9.1 | 2.2 | 1.1 |
| Total Current Assets | 438.1 | 569.8 | 534.7 | 269.5 | 76.4 |
| PP&E | 120.2 | 121.4 | 64.7 | 26.0 | 24.4 |
| Intangible Assets | 36.4 | 1.3 | 1.4 | 2.5 | 0 |
| Goodwill | 52.1 | 0.8 | 0.8 | 0.8 | 0 |
| Long Term Investments | 0 | 7.9 | 8.7 | 0 | 0 |
| Other Long Term Assets | 6.9 | 7.9 | 8.7 | 0.7 | 0.7 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 653.7 | 701.3 | 610.3 | 298.6 | 101.4 |
| LIABILITIES | |||||
| Accounts Payable | 4.0 | 4.6 | 2.8 | 1.1 | 1.3 |
| Short Term Debt | 12.3 | 12.0 | 1.5 | 2.0 | 77 K |
| Other Current Liabilities | 40.5 | 27.0 | 32.3 | 19.7 | 5.1 |
| Total Current Liabilities | 93.2 | 100.3 | 46.7 | 23.1 | 6.7 |
| Long Term Debt | 44.5 | 45.0 | 10.0 | 14.1 | 15.6 |
| Deferred Tax Income | 1.3 | 0.5 | 0 | 0 | (2.3) |
| Other Liabilities | 0 | 0 | 4.1 | 451.0 | 203.4 |
| Total Liabilities | 190.3 | 215.5 | 67.4 | 504.9 | 225.7 |
| EQUITY | |||||
| Common Stock | 2 K | 2 K | 2 K | 0 | 0 |
| Retained Earnings | (967.6) | (639.6) | (400.1) | (213.6) | (126.6) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | (0.1) | 0 | 0 |
| Total Equity | 463.4 | 485.8 | 542.9 | (206.3) | (124.3) |
| Total Liabilities and Equity | 653.7 | 701.3 | 610.3 | 298.6 | 101.4 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 207.9 | 175.5 | 170.3 | 165.8 | 165.8 |